We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
Turnover
41.45%
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.35%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.96%
AUM
$161M
AUM Growth
+$3.67M
(+2.3%)
Cap. Flow
+$2.82M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
38.31%
Holding
133
New
17
Increased
38
Reduced
32
Closed
10
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.4
years
Top 20 Avg Time Held
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$3.13M |
| 2 |
SPDR Gold Trust
GLD
|
+$1.27M |
| 3 |
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
|
+$763K |
| 4 |
IBDM
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
|
+$757K |
| 5 |
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
|
+$670K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$3.58M |
| 2 |
Marathon Petroleum
MPC
|
+$696K |
| 3 |
Bristol-Myers Squibb
BMY
|
+$690K |
| 4 |
Kroger
KR
|
+$657K |
| 5 |
Amazon
AMZN
|
+$434K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.95% |
| 2 | Consumer Discretionary | 13.43% |
| 3 | Healthcare | 13.14% |
| 4 | Technology | 12.28% |
| 5 | Communication Services | 10.77% |
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2019 Portfolio in Review
As of Q2 2019, Bellecapital held 133 positions worth $161M, up 2.3% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Bellecapital's Q2 2019 filing shows 17 new, 38 increased, 32 reduced and 10 closed positions. Its largest new stake was Alcon: 53,356 shares worth $3.29M. The largest sale was JD.com, an estimated $3.58M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bellecapital's largest Q2 2019 buy was Alcon: 53,356 shares worth $3.29M.
- Bellecapital added most to SPDR Gold Trust in Q2 2019, an estimated $1.27M increase.
- Bellecapital's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $690K.
- Bellecapital fully exited JD.com in Q2 2019, selling an estimated $3.58M.
- Bellecapital's ten largest holdings make up 38% of its $161M portfolio in Q2 2019.
- Bellecapital opened 17 new positions and closed 10 in Q2 2019.
- Bellecapital's portfolio value rose 2.3% quarter-over-quarter to $161M.
Based on Bellecapital's 13F filing for Q2 2019, filed 22 Jul 2019.